Comparison between empiric pharmacological therapy in a patient with healthcare-associated meningitis as opposed to a patient with community-acquired bacterial meningitis.

How does the empiric pharmacological therapy differ in a patient with healthcare-associated meningitis (such as a neurosurgical patient with an external ventricular drain) as compared to a healthy adult with community-acquired bacterial meningitis? Explain your rationale.